Glutathione as a Redox Biomarker in Mitochondrial Disease—Implications for Therapy

Technical advances in the ability to measure mitochondrial dysfunction are providing new insights into mitochondrial disease pathogenesis, along with new tools to objectively evaluate the clinical status of mitochondrial disease patients. Glutathione (l-ϒ-glutamyl-l-cysteinylglycine) is the most abu...

Descripción completa

Detalles Bibliográficos
Autores principales: Enns, Gregory M., Cowan, Tina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447941/
https://www.ncbi.nlm.nih.gov/pubmed/28467362
http://dx.doi.org/10.3390/jcm6050050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447941/
https://www.ncbi.nlm.nih.gov/pubmed/28467362
http://dx.doi.org/10.3390/jcm6050050

Ejemplares similares